logo

For the Inventor, By the Inventor

South San Francisco, CA, United States of America

Threshold Pharmaceuticals, Inc.


USPTO Granted Patents = 19



Trademarks = 2

Forward Citations = 200

Loading Chart...
Loading Chart...

19 inventors (with patents filed for the assignee):

goldMedal Mark D Matteucci (12 out of 65 patents)

silverMedal Jian-Xin Duan (10 out of 18 patents)

bronzeMedal George Tidmarsh (7 out of 17 patents)

4.  Hailong Jiao (6 out of 12 patents)

5.  Photon Rao (3 out of 4 patents)

6.  Charles Praray Hart (2 out of 5 patents)

7.  Stewart Kroll (2 out of 3 patents)

8.  Jacob Kaizerman (2 out of 2 patents)

9.  Tao Chen (1 out of 164 patents)

10.  Yeyu Cao (1 out of 7 patents)

11.  Xiaohong Cai (1 out of 7 patents)

12.  Fanying Meng (1 out of 1 patent)

13.  Jessica Sun (1 out of 1 patent)

14.  John G Curd (1 out of 1 patent)

15.  Damian Handisides (1 out of 1 patent)


19 patents:

1. 9254299 - Administration of hypoxia activated prodrugs in combination with Chk1 inhibitors for treating cancer (2016-02-09),
2. 9226932 - Phosphoramidate alkylator prodrugs (2016-01-05),
3. 9205098 - Anti-cancer therapies (2015-12-08),
4. 8946275 - Treatment of cancer using hypoxia activated prodrugs (2015-02-03),
5. 8765690 - Treatment of cancer with glufosfamide in patients not receiving insulin therapy (2014-07-01),
6. 8664204 - Phosphoramidate alkylator prodrugs (2014-03-04),
7. 8575188 - Camptothecin derivatives (2013-11-05),
8. 8552048 - Phosphoramidate alkylator prodrugs for the treatment of cancer (2013-10-08),
9. 8507464 - Phosphoramidate alkylator prodrugs (2013-08-13),
10. 8318683 - Anti-cancer therapies (2012-11-27),
11. 8309554 - Hypoxia activated drugs of nitrogen mustard alkylators (2012-11-13),
12. 8299088 - Compositions and methods for treating cancer (2012-10-30),
13. 8003625 - Phosphoramidate alkylator prodrugs (2011-08-23),
14. 7560230 - Method for determining susceptibility of tumor to treatment with anti-neoplastic agent (2009-07-14),
15. 7550496 - Compositions and methods for treating cancer (2009-06-23),
Threshold Pharmaceuticals, Inc. is a biotechnology company that focuses on the discovery and development of innovative medicines for the treatment of cancer. With a dedicated team of scientists and researchers, Threshold Pharmaceuticals aims to improve patient outcomes by delivering targeted therapies that address the underlying mechanisms of cancer. Visit their website to learn more about their groundbreaking research and pipeline of potential cancer treatments.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

19 Patents

#62 in South San Francisco, CA

#3,967 in California

#16,593 in US

#31,684 in the World

...
South San Francisco, CA, United States of America

Threshold Pharmaceuticals, Inc.

Forward Citations = 200

19 inventors:

goldMedal Mark D Matteucci (12 out of 65 patents)

silverMedal Jian-Xin Duan (10 out of 18 patents)

bronzeMedal George Tidmarsh (7 out of 17 patents)

4.  Hailong Jiao (6 out of 12 patents)

5.  Photon Rao (3 out of 4 patents)

Please report any incorrect information to support@idiyas.com
Loading…